Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART After First-Line Failure Among South Indian HIV-Infected Patients
Journal of the International Association of Physicians in AIDS Care
doi 10.1177/1545109710382780
Full Text
Open PDFAbstract
Available in full text
Date
January 24, 2011
Authors
Publisher
SAGE Publications